Trending...
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- 'Public Speaking Without Panic' Launches to Help Leaders Speak with Confidence
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
CANTON, Mich.--(BUSINESS WIRE)--MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global operations to support Sponsors with complex studies and submissions.
Bringing more than 25 years of statistics experience, Dr. Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across various statistics, biometrics, and biostatistics functions. In addition, he completed his Ph.D. in Statistics from Kansas State University.
"At MMS, we pride ourselves on being able to provide our Sponsors with the right experts to meet their goals," said Michelle Gayari, Executive Vice President, Global Operational Excellence and Innovation, MMS. "With the addition of Dr. Chartier and his extensive experience in biostatistics and submissions planning to our global team, we continue to build on our best-in-class clinical trial design and data solutions for Sponsors and patients."
Dr. Chartier's responsibilities as Principal Advisor of Biostatistics and Submissions Planning include:
"I am excited to join an organization with a proven track record, being able to get closer to the science and the data, and consulting with other drug developers," said Dr. Kevin Chartier. "I plan on building upon this success and strive to provide MMS Sponsors with innovative fit-for-purpose quantitative development strategies and study options to ensure optimal decision making. I'm looking forward to providing educational opportunities for MMS colleagues and Sponsors who desire these services as well."
More on Michimich.com
Additionally, Dr. Chartier will continue his mission of ensuring statistical and quantitative experts are full drug development partners shaping the evolution of drug development.
MMS was recently named a Detroit Free Press Top Workplace in 2021.
Learn more about MMS at www.mmsholdings.com/
About MMS Holdings
MMS is an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and was named a Detroit Free Press Top Workplace in 2021.
For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
More on Michimich.com
Contacts
Media Contact
Avery Zimmerman
734-738-5055
media@mmsholdings.com
Bringing more than 25 years of statistics experience, Dr. Chartier has held positions at Astellas Pharma, Novartis, Wyeth, Pfizer, and United BioSource Corporation across various statistics, biometrics, and biostatistics functions. In addition, he completed his Ph.D. in Statistics from Kansas State University.
"At MMS, we pride ourselves on being able to provide our Sponsors with the right experts to meet their goals," said Michelle Gayari, Executive Vice President, Global Operational Excellence and Innovation, MMS. "With the addition of Dr. Chartier and his extensive experience in biostatistics and submissions planning to our global team, we continue to build on our best-in-class clinical trial design and data solutions for Sponsors and patients."
Dr. Chartier's responsibilities as Principal Advisor of Biostatistics and Submissions Planning include:
- Acting as the senior technical reviewer for complex biostatistics studies
- Advising Sponsors on biostatistics methods and efficiencies for health authority submissions
- Contributing to MMS' emerging biometrics service areas, data science using real world evidence and built-for-purpose technology, Datacise™ , adaptive trial design, and decentralized clinical trials (DCTs)
- Leading complex biostatistics studies, programs and submissions across therapeutic areas and extending to rare diseases
"I am excited to join an organization with a proven track record, being able to get closer to the science and the data, and consulting with other drug developers," said Dr. Kevin Chartier. "I plan on building upon this success and strive to provide MMS Sponsors with innovative fit-for-purpose quantitative development strategies and study options to ensure optimal decision making. I'm looking forward to providing educational opportunities for MMS colleagues and Sponsors who desire these services as well."
More on Michimich.com
- Top 5 Mistakes Entrepreneurs Make When Applying for SBA Loans
- Michigan Computer Supplies Expands Reach into Livingston County with New Brighton Service Offerings
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Delta Industrial Provides Custom Flatwork for Factory Floors
Additionally, Dr. Chartier will continue his mission of ensuring statistical and quantitative experts are full drug development partners shaping the evolution of drug development.
MMS was recently named a Detroit Free Press Top Workplace in 2021.
Learn more about MMS at www.mmsholdings.com/
About MMS Holdings
MMS is an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and was named a Detroit Free Press Top Workplace in 2021.
For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.
More on Michimich.com
- American Plastic Solutions Launches FAQ to Provide Tailored Plastic Fabrication Solutions
- AdviCoach of Southeast Michigan Helps Business Owners at Every Stage
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
Contacts
Media Contact
Avery Zimmerman
734-738-5055
media@mmsholdings.com
Filed Under: Business
0 Comments
Latest on Michimich.com
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- 'Public Speaking Without Panic' Launches to Help Leaders Speak with Confidence
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Rocket Companies Completes Acquisition of Redfin
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
- NEW CHILDREN'S BOOK RELEASE: "Mommy, Where Is My Daddy?" by Tracy L. Gray
- UNIVERSAL MUSIC GROUP AND THE UCLA HERB ALPERT SCHOOL OF MUSIC ESTABLISH THE BERRY GORDY MUSIC INDUSTRY SCHOLARSHIP TO HONOR THE LEGACY OF A MUSIC PIONEER
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence